Zentek (NASDAQ:ZTEK) Trading 3.2% Higher – Still a Buy?

Shares of Zentek Ltd. (NASDAQ:ZTEK) traded up 3.2% on Friday . The company traded as high as $0.99 and last traded at $0.98. 20,626 shares traded hands during trading, a decline of 46% from the average session volume of 38,149 shares. The stock had previously closed at $0.95.

Zentek Stock Up 3.2 %

The company has a current ratio of 1.83, a quick ratio of 1.48 and a debt-to-equity ratio of 0.01. The firm has a market cap of $102.21 million, a PE ratio of -14.00 and a beta of 1.30. The stock has a fifty day simple moving average of $1.06 and a two-hundred day simple moving average of $0.95.

Zentek (NASDAQ:ZTEK) last issued its quarterly earnings data on Wednesday, February 12th. The company reported ($0.01) EPS for the quarter. Zentek had a negative return on equity of 58.13% and a negative net margin of 16,555.32%.

Institutional Trading of Zentek

Hedge funds and other institutional investors have recently bought and sold shares of the company. Two Sigma Securities LLC purchased a new stake in Zentek in the fourth quarter worth approximately $31,000. Anson Funds Management LP bought a new position in shares of Zentek during the fourth quarter valued at approximately $145,000. Finally, Scotia Capital Inc. raised its holdings in shares of Zentek by 5.7% during the fourth quarter. Scotia Capital Inc. now owns 958,771 shares of the company’s stock valued at $867,000 after acquiring an additional 51,744 shares in the last quarter. Hedge funds and other institutional investors own 0.77% of the company’s stock.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.